Spironolactone tablets
Reason category: Sterility / contamination
FDA recall number D-0574-2025
Heart / fluid
Spironolactone 25 mg tablet
Public data on spironolactone from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.
$0.0426
NADAC per ea (2026-11)
approximate acquisition cost, not a retail price
-25%
change over five years
peak $0.0830 in 2014-02
19
approved generic applications (ANDAs) on record for Spironolactone
12 with a product still marketed · first 1980
Not listed
in FDA's current shortage list
Spironolactone Tablet: To Be Discontinued
NADAC per unit, monthly
SPIRONOLACTONE 25 MG TABLETShow as table
| Month | NADAC per unit ($) |
|---|---|
| 2013-11 | 0.07812 |
| 2014-02 | 0.08298 |
| 2014-05 | 0.07619 |
| 2014-08 | 0.07442 |
| 2014-11 | 0.06981 |
| 2015-02 | 0.07008 |
| 2015-05 | 0.06567 |
| 2015-08 | 0.06415 |
| 2015-11 | 0.06373 |
| 2016-02 | 0.06560 |
| 2016-05 | 0.06599 |
| 2016-08 | 0.06520 |
| 2016-11 | 0.06416 |
| 2017-02 | 0.06131 |
| 2017-05 | 0.06176 |
| 2017-08 | 0.06346 |
| 2017-11 | 0.06619 |
| 2018-02 | 0.05876 |
| 2018-05 | 0.05659 |
| 2018-08 | 0.05781 |
| 2018-11 | 0.07761 |
| 2019-02 | 0.07248 |
| 2019-05 | 0.06656 |
| 2019-08 | 0.06504 |
| 2019-11 | 0.06828 |
| 2020-02 | 0.06433 |
| 2020-05 | 0.06123 |
| 2020-08 | 0.05681 |
| 2020-11 | 0.05808 |
| 2021-02 | 0.05816 |
| 2021-05 | 0.05788 |
| 2021-08 | 0.05801 |
| 2021-11 | 0.05650 |
| 2022-02 | 0.05012 |
| 2022-05 | 0.05083 |
| 2022-08 | 0.04981 |
| 2022-11 | 0.05026 |
| 2023-02 | 0.04457 |
| 2023-05 | 0.05333 |
| 2023-08 | 0.05235 |
| 2023-11 | 0.05314 |
| 2024-02 | 0.05159 |
| 2024-05 | 0.04657 |
| 2024-08 | 0.04906 |
| 2024-11 | 0.04637 |
| 2025-02 | 0.04776 |
| 2025-05 | 0.05088 |
| 2025-08 | 0.05032 |
| 2025-11 | 0.05020 |
| 2026-02 | 0.04667 |
| 2026-05 | 0.04489 |
| 2026-08 | 0.04317 |
| 2026-11 | 0.04260 |
Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.
Recall records mentioning spironolactone
openFDA enforcement records, by year reported.
| 2025 | 1 |
| 2021 | 3 |
| 2020 | 2 |
| 2016 | 1 |
| 2015 | 1 |
| 2013 | 3 |
11 records since 2012. A record is one product or lot, not one recall event. Combination products that contain spironolactone are included.
What these numbers mean
NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.
Most recent recall records
Spironolactone product
Reason category: Sterility / contamination
FDA recall number D-0804-2021
Spironolactone tablets
Reason category: Labeling or packaging error
FDA recall number D-0303-2021
Spironolactone tablets
Reason category: Labeling or packaging error
FDA recall number D-0304-2021
Spironolactone product
Reason category: Failed specifications (other)
FDA recall number D-1426-2020
Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.
Articles that mention spironolactone
1 GxRadar article cite or discuss this drug.